Salarius Pharmaceuticals, Inc. (SLRX)
NASDAQ: SLRX · Real-Time Price · USD
0.6300
+0.0307 (5.12%)
At close: Aug 1, 2025, 4:00 PM
0.6434
+0.0134 (2.13%)
After-hours: Aug 1, 2025, 7:58 PM EDT

Exscientia Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2020
13332222
Upgrade
Market Cap Growth
-42.28%3.58%-26.56%-84.44%3.42%41.29%
Upgrade
Enterprise Value
-0-0-5-13-913
Upgrade
Last Close Price
0.631.845.2012.2499.12182.00
Upgrade
PS Ratio
----12.184.14
Upgrade
PB Ratio
21.201.750.480.340.580.98
Upgrade
P/TBV Ratio
21.661.750.480.340.751.63
Upgrade
EV/Sales Ratio
-----2.46
Upgrade
Debt / Equity Ratio
1.810.150.06--0.02
Upgrade
Asset Turnover
----0.060.27
Upgrade
Quick Ratio
0.791.614.543.2213.845.40
Upgrade
Current Ratio
1.011.985.023.4014.295.70
Upgrade
Return on Equity (ROE)
-300.16%-164.02%-160.07%-128.73%-41.94%-44.91%
Upgrade
Return on Assets (ROA)
-98.32%-74.59%-75.90%-51.76%-24.35%-25.07%
Upgrade
Return on Capital (ROIC)
-180.22%-98.05%-100.98%-58.48%-26.10%-28.86%
Upgrade
Earnings Yield
-415.61%-210.27%-489.95%-906.79%-56.99%-33.94%
Upgrade
FCF Yield
-324.81%-170.66%-501.81%-504.79%-45.53%-47.61%
Upgrade
Buyback Yield / Dilution
-168.54%-135.79%-53.66%-28.40%-165.53%-376.61%
Upgrade
Updated Mar 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q